Serial Proton MR Spectroscopic Imaging of Recurrent Malignant Gliomas after Gamma Knife Radiosurgery

References

1. ↵
   Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD. Survival benefits of stereotactical radiosurgery for patients with malignant glial neoplasms. Neurosurgery 1997;41:776-785

   CrossRefPubMed
2. Loeffler JS, Alexander EI, Shea M, et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992;10:1379-1385

   Abstract/FREE Full Text
3. Mehta MP, Masciopinto J, Rozental J, et al. Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 1992;24:619-625

   PubMedWeb of Science
4. ↵
   Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34:463-469

   CrossRefPubMedWeb of Science
5. ↵
   Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;87:525-534

   PubMedWeb of Science
6. ↵
   Nelson SJ, Day MR, Buffone PJ, et al. Alignment of volume MR images and high resolution [18F]fluorodeoxyglucose PET images for the evaluation of patients with brain tumors. J Comput Assist Tomogr 1997;21:183-191

   CrossRefPubMedWeb of Science
7. ↵
   Nelson SJ, Huhn S, Vigneron DB, et al. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. J Magn Reson Imaging 1997;7:1146-1152

   PubMed
8. Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed 1999;12:123-138

   CrossRefPubMed
9. ↵
   Star-Lack J, Vigneron DB, Pauly J, Kurhanewicz J, Nelson SJ. Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging 1997;7:745-757

   PubMed
10. ↵
    Wald LL, Moyher SE, Day MR, Nelson SJ, Vigneron DB. Proton spectroscopic imaging of the human brain using phased array detectors. Magn Reson Med 1995;34:440-445

    PubMed
11. ↵
    Nelson SJ, Nalbandian AB, Proctor E, Vigneron DB. Registration of images from sequential MR studies of the brain. J Magn Reson Imaging 1994;4:877-883

    PubMedWeb of Science
12. ↵
    Moyher SE, Vigneron DB, Nelson SJ. Surface coil MR imaging of the human brain with an analytic reception profile correction. J Magn Reson Imaging 1995;5:139-144

    PubMed
13. ↵
    Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541-548

    PubMedWeb of Science
14. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686

    PubMed
15. ↵
    Graves EE, Nelson SJ, Vigneron DB, et al. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 2000;46:319-328

    CrossRefPubMed
16. ↵
    Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of inoperable brain gliomas: response to radiation therapy. J Neurooncol 1993;17:27-35

    CrossRefPubMed
17. ↵
    Richards T, Budinger TF. NMR imaging and spectroscopy of the mammalian central nervous system after heavy ion radiation. Radiat Res 1988;113:79-101

    CrossRefPubMed
18. ↵
    Usenius T, Usenius JP, Tenhunen M, et al. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 1995;33:719-724

    CrossRefPubMedWeb of Science
19. ↵
    Szigety SK, Allen PS, Huyser-Wierenga D, Urtasun RC. The effect of radiation on normal human CNS as detected by NMR spectroscopy. Int J Radiat Oncol Biol Phys 1993;25:695-701

    PubMedWeb of Science
20. ↵
    Estève F, Rubin C, Grand S, Kolodie H, Le Bas JF. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 1998;40:279-286

    CrossRefPubMedWeb of Science
21. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177:633-641

    PubMedWeb of Science
22. Sijens PE, Vecht CJ, Levendag PC, van Dijk P, Oudkerk M. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer: unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. Invest Radiol 1995;30:738-744

    CrossRefPubMed
23. ↵
    Houkin K, Kamada K, Sawamura Y, Iwasaki Y, Abe H, Kashiwaba T. Proton magnetic resonance spectroscopy (1H-MRS) for the evaluation of treatment of brain tumours. Neuroradiology 1995;37:99-103

    PubMed
24. ↵
    Haymaker W. Effect of ionizing radiation on nervous tissue. In: Bourne GH, ed. The Structure and Function of Nervous Tissue. New York: Academic Press 1972;441-513
25. Prasad KN. CRC Handbook of Radiobiology.. Boca Raton: CRC Press 1984;131-139
26. ↵
    van der Kogel A. Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br J Cancer 1986;53:207-217
27. ↵
    Tomoi M, Kimura H, Yoshida M, et al. Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy. Invest Radiol 1997;32:288-296

    PubMed
28. ↵
    Kuesel AC, Sutherland GR, Halliday W, Smith ICP. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149-155

    PubMed
29. ↵
    Negendank W, Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticancer Res 1996;16:1533-1538

    PubMedWeb of Science
30. ↵
    Sijens PE, van den Bent MJ, Nowak PJ, van Dijk P, Oudkerk M. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997;37:222-225

    PubMed
31. ↵
    Lin A, Ross BD. The effect of gadolinium on quantitative short-echo time single voxel MRS of treated and untreated brain tumors. Presented at the eighth annual meeting of the International Society of Magnetic Resonance in Medicine, Denver, CO, April 2000
32. ↵
    Cairncross JG, MacDonald DR, Pexman JH, Ives FJ. Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology 1988;38:724-726

    Abstract/FREE Full Text